Platelet mRNA: the meaning behind the message
Open accessThe DOI matches its Crossref record.
Abstract
PURPOSE OF REVIEW: It is now well appreciated that megakaryocytes invest platelets with a diverse repertoire of messenger RNAs (mRNAs), which are competent for translation. Herein we describe what is currently known regarding the expression, function, and clinical significance of mRNAs in platelets. RECENT FINDINGS: Although mRNA was detected in platelets nearly 30 years ago, we are only beginning to understand the roles of mRNA in platelet biology and human disease. Recent studies have shown that megakaryocytes specifically sort, rather than randomly transfer, mRNA to platelets during thrombopoiesis. As a result, platelets are released into the circulation with thousands of mRNAs. The emergence of next-generation RNA sequencing has demonstrated that platelet mRNAs possess classic structural features, which include untranslated regions and open reading frames. There is also growing evidence that platelet mRNA expression patterns are altered in human disease. SUMMARY: Intense investigation of platelet mRNA has shed considerable light on predicted functions of platelets and identified previously unrecognized attributes of platelets. Lessons learned from platelet mRNA is presented in this review.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Jamboree, P. I. T. 1. H. C. A., Lun, A. T. L., Riesenfeld, S., Andrews, T., Dao, T. P., Gomes, T., & Marioni, J. C. (2019) · Genome Biology · doi:10.1186/s13059-019-1662-y · Cited by 1,097
Yipp, B. G., & Kubes, P. (2013) · Blood · doi:10.1182/blood-2013-04-457671 · Cited by 989
Human platelet lysate: Replacing fetal bovine serum as a gold standard for human cell propagation?
Burnouf, T., Strunk, D., Koh, M. B. C., & Schallmoser, K. (2016) · Biomaterials · doi:10.1016/j.biomaterials.2015.10.065 · Cited by 521
Sepsis therapies: learning from 30 years of failure of translational research to propose new leads
Cavaillon, J., Singer, M., & Skirecki, T. (2020) · EMBO Molecular Medicine · doi:10.15252/emmm.201810128 · Cited by 319
Platelets as Cellular Effectors of Inflammation in Vascular Diseases
Rondina, M. T., Weyrich, A. S., & Zimmerman, G. A. (2013) · Circulation Research · doi:10.1161/circresaha.113.300512 · Cited by 312
Self-citationPotential mechanisms of target-independent uptake and toxicity of antibody-drug conjugates
Mahalingaiah, P. K., Ciurlionis, R., Durbin, K. R., Yeager, R. L., Philip, B. K., Bawa, B., Mantena, S. R., Enright, B. P., Liguori, M. J., & Van Vleet, T. R. (2019) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2019.04.008 · Cited by 286
Systemic inflammation in colorectal cancer: Underlying factors, effects, and prognostic significance
Tuomisto, A. E., Mäkinen, M. J., & Väyrynen, J. P. (2019) · World Journal of Gastroenterology · doi:10.3748/wjg.v25.i31.4383 · Cited by 271
Role of Platelet Mitochondria: Life in a Nucleus-Free Zone
Melchinger, H., Jain, K., Tyagi, T., & Hwa, J. (2019) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2019.00153 · Cited by 208
Non-genomic effects of nuclear receptors: insights from the anucleate platelet
Unsworth, A. J., Flora, G. D., & Gibbins, J. M. (2018) · Cardiovascular Research · doi:10.1093/cvr/cvy044 · Cited by 54
“There is a growing consensus that these RNAs are not subjected to a random transfer by megakaryocytes but are specifically sorted and are competent for translation within platelets.(17,18) Moreover, there is evidence to suggest that plateletderived microparticles may deliver platelet mRNAs into other nucleated cells,…”
Lucas, A. T., Moody, A., Schorzman, A. N., & Zamboni, W. C. (2021) · Antibodies · doi:10.3390/antib10030030 · Cited by 40
Shvetcov, A., Thomson, S., Spathos, J., Cho, A.-N., Wilkins, H. M., Andrews, S. J., Delerue, F., Couttas, T. A., Issar, J. K., Isik, F., et al. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241915011 · Cited by 12
“This suggests that the bulk of mRNA comes from the various white blood cells or platelets [50,51], highlighting that there may be peripheral dysfunction in these diseases driven by these cell types.”
Background
Metadata
- Authors
- Rowley, J. W., Schwertz, H., & Weyrich, A. S.
- Venue
- Current Opinion in Hematology
- Published
- 2012-09
- Volume
- 19
- Issue
- 5
- Pages
- 385-391
- ISSN
- 1065-6251 (ISSN-L)
- OpenAlex
- W1968949305
- Cited by
- 145
- References
- 0
- FWCI
- 4.99
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.